imatinib has been researched along with DDR1-IN-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Canning, P; Choi, HG; Ezell, SA; Gray, NS; Griffin, JD; Kim, HG; Lee, SW; Liu, F; Liu, Q; Mandinova, A; Tan, L; Wang, J; Weisberg, EL; Wu, H; Zhao, Z | 1 |
| Ding, K; Li, Y; Lu, X; Ren, X | 1 |
1 review(s) available for imatinib and DDR1-IN-1
| Article | Year |
|---|---|
Small molecule discoidin domain receptor kinase inhibitors and potential medical applications.
Topics: Amino Acid Sequence; Animals; Discoidin Domain Receptors; Drug Discovery; Humans; Inflammation; Ligands; Models, Molecular; Molecular Sequence Data; Neoplasms; Protein Conformation; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Small Molecule Libraries | 2015 |
1 other study(ies) available for imatinib and DDR1-IN-1
| Article | Year |
|---|---|
Discovery of a potent and selective DDR1 receptor tyrosine kinase inhibitor.
Topics: Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Discoidin Domain Receptor 1; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Models, Molecular; Neoplasms; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases | 2013 |